drugset / Trial / NCT00459056

The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients

NCT00459056

Phase 3 Completed 25 enrolled St. Paul Heart Clinic GlaxoSmithKline · collab
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to compare the effects of two different combination therapies for high blood pressure on vascular health.

Timeline

Start
2007-04
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 40 mg Oral
Subject Hydrochlorothiazide Unknown 25 mg Oral
Background LISINOPRIL ANHYDROUS Small molecule 20 mg Oral